Clinical Trials Browser

Terminated × Recurrence × eribulin × Clear all

NCT03795012 2021-08-31

Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis, Recurrence